Открыть главное меню
Главная
Случайная
Войти
Настройки
О hpluswiki
Отказ от ответственности
hpluswiki
Найти
Редактирование:
LCAT
Внимание:
Вы не вошли в систему. Ваш IP-адрес будет общедоступен, если вы запишете какие-либо изменения. Если вы
войдёте
или
создадите учётную запись
, её имя будет использоваться вместо IP-адреса, наряду с другими преимуществами.
Анти-спам проверка.
Не
заполняйте это!
Phosphatidylcholine-sterol acyltransferase precursor (EC 2.3.1.43) (1-alkyl-2-acetylglycerophosphocholine esterase) (EC 3.1.1.47) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) (Platelet-activating factor acetylhydrolase) (PAF acetylhydrolase) ==Publications== {{medline-entry |title=Absorption and lipoprotein transport of sphingomyelin. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/16251722 |abstract=Dietary sphingomyelin (SM) is hydrolyzed by intestinal alkaline sphingomyelinase and neutral ceramidase to sphingosine, which is absorbed and converted to palmitic acid and acylated into chylomicron triglycerides ([[TG]]s). SM digestion is slow and is affected by luminal factors such as bile salt, cholesterol, and other lipids. In the gut, SM and its metabolites may influence [[TG]] hydrolysis, cholesterol absorption, lipoprotein formation, and mucosal growth. SM accounts for approximately 20% of the phospholipids in human plasma lipoproteins, of which two-thirds are in LDL and VLDL. It is secreted in chylomicrons and VLDL and transferred into HDL via the [[ABCA1]] transporter. Plasma SM increases after periods of large lipid loads, during suckling, and in type II hypercholesterolemia, cholesterol-fed animals, and apolipoprotein E-deficient mice. SM is thus an important amphiphilic component when plasma lipoprotein pools expand in response to large lipid loads or metabolic abnormalities. It inhibits lipoprotein lipase and [[LCAT]] as well as the interaction of lipoproteins with receptors and counteracts LDL oxidation. The turnover of plasma SM is greater than can be accounted for by the turnover of LDL and HDL particles. Some SM must be degraded via receptor-mediated catabolism of chylomicron and VLDL remnants and by scavenger receptor class B type I receptor-mediated transfer into cells. |mesh-terms=* Aging * Amidohydrolases * Animals * Animals, Newborn * Apolipoproteins E * Biological Transport, Active * Cell Differentiation * Cell Proliferation * Ceramidases * Cholesterol, Dietary * Chylomicrons * Dietary Fats * Humans * In Vitro Techniques * Infant, Newborn * Intestinal Absorption * Lipoproteins * Models, Biological * Neutral Ceramidase * Sphingomyelin Phosphodiesterase * Sphingomyelins * Triglycerides |full-text-url=https://sci-hub.do/10.1194/jlr.M500357-JLR200 }} {{medline-entry |title=Age-strain interrelations in lipid metabolism of rats. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/7242272 |abstract=Various aspects of lipid metabolism were compared in Fisher 344 (F) and Sprague-Dawley (SD) rats aged 2, 6, 12, 18 and 24 months. The analyses included free and total cholesterol of serum and liver, [[LCAT]], hepatic HMG-CoA reductase, cholesterol 7 alpha-hydroxylase, fatty acid synthetase, acetyl CoA carboxylase and cholesterol synthesis from acetate or mevalonate. The body weight of SD rats increases with age whereas that of F rats plateaus at 9-12 months. Liver and aorta cholesterol levels were comparable for the 2 strains. Serum cholesterol varied but was usually lower in F rats. HMG-CoA reductase and cholesterol 7 alpha-hydroxylase activities were not significantly different. Cholesterol synthesis from acetate was significantly higher only in 2-month-old F rats; synthesis from mevalonate was similar at each level. Acetyl CoA carboxylase and fatty acid synthetase activity were generally higher in F rats at every age level. The major difference between F and SD rats is in their pattern of weight gain with age. Differences in lipid metabolism are most marked between the young (2-month) rats. |mesh-terms=* Aging * Animals * Body Weight * Cholesterol * Cholesterol 7-alpha-Hydroxylase * Hydroxymethylglutaryl CoA Reductases * Lipid Metabolism * Liver * Male * Phosphatidylcholine-Sterol O-Acyltransferase * Rats * Species Specificity |full-text-url=https://sci-hub.do/10.1007/BF02535679 }} {{medline-entry |title=Population-based reference values for lecithin-cholesterol acyltransferase ([[LCAT]]). |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/7115467 |abstract=Plasma unesterified cholesterol is converted to cholesteryl ester by the enzyme lecithin-cholesterol acyltransferase ([[LCAT]]). Plasma levels of [[LCAT]] were measured by a sensitive double antibody radioimmunoassay in a sample from an adult employee population, ages 20-59 years, in the Pacific Northwest. After adjusting for differences in relative body mass, women had significantly higher [[LCAT]] levels (5.90 /- 1.06, n = 154) than men (5.49 /- 0.89, n = 83). For ages 20-59 years, [[LCAT]] levels showed a slight association with age: r = 0.13 for men and 0.29 for women. [[LCAT]] was positively correlated with relative body mass, total cholesterol, and LDL cholesterol. Men who smoked cigarettes had significantly lower [[LCAT]] mass than men who did not smoke cigarettes. No statistical differences in mean [[LCAT]] values were found between drinkers and nondrinkers. The 5th percentile [[LCAT]] value was 4.3 micrograms/ml for both men and women not using hormones. The 95th percentile value was 7.3 micrograms/ml for men and 7.8 micrograms/ml for women regardless of hormone use. Subjects phenotypically [[LCAT]]-deficient by clinical criteria and by the absence or near absence of [[LCAT]] activity had levels of [[LCAT]] mass well below the reference values: 0.73 /- 0.70, range 0.10 micrograms/ml to 2.65 micrograms/ml, n = 20. Parents or children of [[LCAT]]-deficient subjects, i.e., obligate heterozygotes for familial [[LCAT]] deficiency, had reduced levels: 3.59 /- 0.69, range 2.59-4.61 micrograms/ml, n = 19. |mesh-terms=* Adult * Aged * Aging * Alcohol Drinking * Body Weight * Cholesterol * Contraceptives, Oral * Estrogens * Female * Health Surveys * Humans * Hypolipoproteinemias * Japan * Lecithin Cholesterol Acyltransferase Deficiency * Male * Middle Aged * Norway * Phosphatidylcholine-Sterol O-Acyltransferase * Population * Reference Values * Smoking * Triglycerides * Washington |full-text-url=https://sci-hub.do/10.1016/0021-9150(82)90036-3 }} {{medline-entry |title=Plasma lecithin:cholesterol acyltransferase -- reference values and effects of xenobiotics. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/6627678 |abstract=Plasma lecithin:cholesterol acyltransferase ([[LCAT]]) has been measured by an enzymatic method. We did not observe any significant sex variations, but age variations were found. In females, [[LCAT]] activities are stable up to 40 years (60 mumol . 1.1 . h-1 at the 50th centile). Also, from 50 years the median increased progressively to 76 mumol . 1-1 . h-1. In males, the activity increased from 52 to 71 mumol . 1-1 . h-1 at the 50th centile in two age groups (15-20 years and 50 years). The effect of some xenobiotics on [[LCAT]] activity was studied. We observed an increase in activity of 33% in males when the daily alcoholic beverage consumption ranged from 0 to more than 0.5 litre of wine or beer. [[LCAT]] activity increased in children who were treated with hypolipidemic drugs (fenofibrate, Lipanthyl). In boys, the mean enzyme activity increased to 35% (p less than 0.05). The increase was greater in girls (75%, p less than 0.01). Treatment with anticonvulsant drugs gave a decrease in [[LCAT]] activity of 32-46%. |mesh-terms=* Adolescent * Adult * Aging * Alcohol Drinking * Anticonvulsants * Child * Child, Preschool * Female * Fenofibrate * Humans * Hypolipidemic Agents * Male * Middle Aged * Phosphatidylcholine-Sterol O-Acyltransferase * Quality Control * Reference Values * Sex Factors |full-text-url=https://sci-hub.do/10.1016/0009-8981(83)90023-2 }} {{medline-entry |title=Age-related changes in the rate of esterification of plasma cholesterol in Fischer-344 rats. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/3959602 |abstract=Plasma cholesterol and triglyceride levels and selected molecular species of plasma cholesteryl esters and triglycerides were determined in 6-, 12-, 15-, 18-, 21-, and 24-month-old Fischer-344 rats. Lecithin:cholesterol acyltransferase ([[LCAT]]) activity was also determined using two independent methods utilizing endogenous and exogenous substrates. Plasma cholesterol levels increased up to 18 months of age and then plateaued. Of the plasma triglyceride molecular species investigated (C50, C52, C54 and C56), only the levels of C52 increased linearly with age. The concentration of other triglyceride molecular species did not change with age. The fractional rate of plasma cholesterol esterification showed a decreasing trend with age, whereas, the net cholesterol esterification rate showed a gradual age related increase. However, this latter parameter remained unchanged with age when the data were normalized for body weight. The cholesterol esterification rates measured using an exogenous substrate (estimating [[LCAT]] enzyme levels) showed essentially no change with age. These data indicate that changes in the levels and/or composition of lipoprotein substrate(s) for [[LCAT]] are likely causes of the observed age-related changes in the fractional rate of plasma cholesterol esterification. The net esterification rate of plasma cholesterol was significantly correlated with the plasma triglyceride levels when the animals for all age groups were treated as one experimental group. |mesh-terms=* Aging * Animals * Cholesterol * Cholesterol Esters * Male * Phosphatidylcholine-Sterol O-Acyltransferase * Rats * Rats, Inbred F344 * Substrate Specificity * Triglycerides |full-text-url=https://sci-hub.do/10.1016/0047-6374(86)90028-x }} {{medline-entry |title=Lecithin: cholesterol acyltransferase activity in children and young adults. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/2719765 |abstract=The association between serum lecithin: cholesterol acyltransferase ([[LCAT]]) activity and demographic and environmental factors, and the correlation of [[LCAT]] activity with serum lipids and lipoproteins were studied in a representative series of 1071 9-24-year-old subjects from East and West Finland. [[LCAT]] activity was determined by a method involving the use of exogenous substrate. Males had higher [[LCAT]] activity than females and subjects from East Finland had significantly higher activity than those from West Finland. [[LCAT]] activity tended to be lowest shortly after puberty. Women using oral contraceptives had significantly lower [[LCAT]] activity than women not using them. Serum [[LCAT]] activity was not associated with body mass index, physical activity index or smoking. Serum [[LCAT]] activity correlated positively with most serum lipid and lipoprotein variables. The highest correlation coefficients were found between [[LCAT]] activity and total cholesterol. [[LCAT]] activity correlated positively with the change in serum total cholesterol which had occurred during the preceding 3 and 6 years in men. Our results suggest that sex hormonal factors are associated with serum [[LCAT]] activity. The results are also in accordance with the idea that activity of [[LCAT]] increases in response to enhanced demands for cholesterol esterification in plasma. |mesh-terms=* Adolescent * Adult * Aging * Child * Child, Preschool * Cholesterol, HDL * Contraceptives, Oral * Coronary Disease * Female * Finland * Humans * Lipoproteins * Male * Phosphatidylcholine-Sterol O-Acyltransferase * Sex Characteristics * Smoking |full-text-url=https://sci-hub.do/10.1016/0021-9150(89)90003-8 }} {{medline-entry |title=Tissue-specific expression, developmental regulation, and chromosomal mapping of the lecithin: cholesterol acyltransferase gene. Evidence for expression in brain and testes as well as liver. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/2600083 |abstract=Lecithin:cholesterol acyltransferase ([[LCAT]]) catalyzes the esterification of cholesterol in high density lipoproteins, thereby facilitating transport of excess cholesterol from peripheral tissues to liver. We report here studies of the developmental, dietary, and genetic control of [[LCAT]] gene expression. In adult male Sprague-Dawley rats fed a standard chow diet [[LCAT]] mRNA was most abundant in liver, a major source of the plasma enzyme, but appreciable levels were also present in brain and testes. Since both brain and testes are isolated from blood by tight cellular barriers, undoubtedly greatly reducing the level of plasma-derived [[LCAT]] in cerebrospinal fluid and testes, the production of [[LCAT]] in these tissues may be important for removal of excess cholesterol. Noteworthy changes in the expression of [[LCAT]] mRNA were observed during development of both rodents and humans. On the other hand, [[LCAT]] mRNA levels were relatively resistant to dietary challenge or to drugs affecting cholesterol metabolism. Since human epidemiological studies have suggested an association between [[LCAT]] levels and variations of high density lipoprotein cholesterol, we examined [[LCAT]] gene polymorphisms in a mouse animal model. Mapping of the [[LCAT]] gene (Lcat) to mouse Chromosome 8 within 2 centimorgans of the Es-2 locus indicates that it does not correspond to any previously mapped loci affecting high density lipoprotein phenotypes in the mouse. |mesh-terms=* Aging * Amino Acid Sequence * Animals * Base Sequence * Brain * Chromosome Mapping * Chromosomes, Human, Pair 16 * Cloning, Molecular * Diet * Embryonic and Fetal Development * Female * Gene Expression * Gene Expression Regulation, Enzymologic * Gene Library * Genes * Humans * Liver * Male * Mice * Mice, Inbred Strains * Molecular Sequence Data * Organ Specificity * Phosphatidylcholine-Sterol O-Acyltransferase * RNA, Messenger * Sequence Homology, Nucleic Acid * Testis * Transcription, Genetic }} {{medline-entry |title=Cholesterol metabolism in mature and immature rats fed animal and plant protein. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/2262808 |abstract=In two feeding experiments immature (180 g) and mature rats (370 g) were fed a semi-purified diet containing 20% of a protein source (casein, wheat gluten, soybean or potato protein) for 4 wk. Food supply was restricted to 15 g daily. As compared to casein, plant proteins induced significantly lower concentrations of plasma total cholesterol and high density lipoprotein (HDL) cholesterol. The plasma cholesterol increase associated with aging was not prevented by consumption of casein, soybean or potato protein, but wheat gluten seemed to be effective. Lecithin-cholesterol acyltransferase ([[LCAT]]) activity was not significantly different in rats of the same age fed different plant proteins, whereas the esterification rate was lower in rats fed casein. With aging the [[LCAT]] activity generally decreased. As compared to the casein groups, the rats fed plant proteins showed higher excretion of fecal neutral and acidic steroids. Among the groups fed plant proteins, the fecal output of steroids was variable. Significantly negative correlations were found between fecal total sterol excretion and plasma total cholesterol or HDL cholesterol, respectively. Plant proteins showed a faster migration rate in the stomach, whereas their migration and absorption were slower in the first half of the small intestine. A relation between nonabsorbed nitrogen-containing substances and sterol excretion was hypothesized. |mesh-terms=* Aging * Amino Acids * Animals * Bile Acids and Salts * Caseins * Cholesterol * Cholesterol, HDL * Cholesterol, LDL * Dietary Proteins * Feces * Glutens * Male * Phosphatidylcholine-Sterol O-Acyltransferase * Plant Proteins * Plant Proteins, Dietary * Rats * Rats, Inbred Strains * Solanum tuberosum * Soybean Proteins * Sterols |full-text-url=https://sci-hub.do/10.1093/jn/120.12.1624 }} {{medline-entry |title=Age related changes in the lipoprotein substrates for the esterification of plasma cholesterol in rats. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/1779703 |abstract=The activity of the enzyme lecithin:cholesterol acyltransferase ([[LCAT]]) and the properties of its lipoprotein substrates have been investigated in 6- and 19-month-old Fischer-344 rats. These studies were carried out to determine the nature of the relationship between the observed hypercholesterolemia and the age-related decrease in the fractional rate of lipoprotein cholesterol esterification. The distribution of [[LCAT]] activity of plasma fractions was determined following gel chromatography and ultracentrifugation respectively. [[LCAT]] activity was found to be associated with the high density lipoprotein (HDL) fraction when rat plasma was passed through a Bio-Gel A-5 M column. Upon density gradient ultracentrifugation for 24 h it was found associated with HDL fraction; d = 1.125-1.21 g/ml. However, following prolonged ultracentrifugation (40 h), the majority of the [[LCAT]] activity was displaced into the lipoprotein-free infranatant (d greater than 1.225 g/ml). The dissociation of [[LCAT]] from its complex with HDL occurred to a smaller extent in aged rat plasma than in young rat plasma. Substrate specificity studies indicated that HDL was a considerably better substrate for [[LCAT]] than very low density lipoproteins (VLDL) in both young and aged rats. In addition, HDL from young rats was a better substrate for [[LCAT]] than the HDL from aged rats. Incubation experiments followed by the isolation of lipoproteins and the subsequent analyses of their cholesterol contents revealed that the age-related hypercholesterolemia was mainly due to an increase in the cholesterol carried by lipoprotein fractions d = 1.025 -1.07 g/ml (LDL HDL1). These and other low density lipoproteins (d less than 1.025 g/ml) were poor substrates for [[LCAT]]. However, these lipoproteins could provide free cholesterol for esterification by first transferring it to HDL (d = 1.07-1.21). The HDL isolated from the plasma of aged rats was enriched with apolipoprotein (apo) E and these lipoprotein particles were found to be inferior substrates for [[LCAT]]. These data suggest that the decreased fractional rate of esterification observed in aged rats is due to the slower utilization of the HDL lipid substrate pool by the enzyme [[LCAT]] as a result of the accumulation of unfavorable substrates (compositionally altered HDL particles) for the [[LCAT]] reaction. |mesh-terms=* Aging * Animals * Cholesterol * Cholesterol Esters * Lipoproteins * Lipoproteins, HDL * Lipoproteins, VLDL * Male * Phosphatidylcholine-Sterol O-Acyltransferase * Rats * Rats, Inbred F344 * Substrate Specificity |full-text-url=https://sci-hub.do/10.1016/0047-6374(91)90008-n }} {{medline-entry |title=Effect of ethinyl estradiol treatment on lipoproteins and [[LCAT]] activity in aged rats. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/1630152 |abstract=The induction of hepatic lipoprotein (apo B/E) have been investigated in Fischer-344 rats. These studies were aimed to determine the mechanism underlying the previously observed (Lee et al., Mech. Ageing Dev., 61 (1991) 85-98) hypercholesterolemia and the age-related decrease in the fractional rate of endogenous cholesterol esterification. Young (5 months) and aged (22 months) male Fischer-344 rats were treated with pharmacological doses (5 mg/kg per day) of ethinyl estradiol (EE) for 7 days. Reduction of plasma cholesterol (57% in young vs 47% in aged rats) and high density lipoprotein cholesterol (64% in young vs 63% in aged rats) occurred in both groups upon EE treatment. Initial low density lipoprotein levels were very low in the plasma of young rats and consequently were not affected by EE treatment. However, in aged rats, the low density lipoprotein levels were much higher initially and were markedly reduced by EE treatment. (18.0 vs 10.0 mg/dl). Very low density lipoproteins were about the same initially but increased in aged rats and decreased in young rats upon EE treatment. Both the lecithin:cholesterol acyltransferase ([[LCAT]]) activity (as determined with a proteoliposome substrate) and the fractional rate (FR) of the endogenous cholesterol esterification decreased in treated animals compared to controls. However, the differences in the FR of the endogenous cholesterol esterification between young and aged rats (observed before treatment) were nearly abolished upon treatment. These data suggest that the previously observed age related decrease in the FR of endogenous cholesterol esterification is due to the accumulation of apolipoprotein E-rich (apo E) lipoproteins.(ABSTRACT TRUNCATED AT 250 WORDS) |mesh-terms=* Aging * Animals * Apolipoproteins E * Cholesterol Esters * Ethinyl Estradiol * Lipoproteins * Lipoproteins, HDL * Liver * Male * Organ Size * Phosphatidylcholine-Sterol O-Acyltransferase * Rats * Rats, Inbred F344 |full-text-url=https://sci-hub.do/10.1016/0047-6374(92)90101-i }}
Описание изменений:
Пожалуйста, учтите, что любой ваш вклад в проект «hpluswiki» может быть отредактирован или удалён другими участниками. Если вы не хотите, чтобы кто-либо изменял ваши тексты, не помещайте их сюда.
Вы также подтверждаете, что являетесь автором вносимых дополнений, или скопировали их из источника, допускающего свободное распространение и изменение своего содержимого (см.
Hpluswiki:Авторские права
).
НЕ РАЗМЕЩАЙТЕ БЕЗ РАЗРЕШЕНИЯ ОХРАНЯЕМЫЕ АВТОРСКИМ ПРАВОМ МАТЕРИАЛЫ!
Отменить
Справка по редактированию
(в новом окне)
Шаблон, используемый на этой странице:
Шаблон:Medline-entry
(
править
)